Molecular mechanisms of cell cycle block by methionine restriction in human prostate cancer cells

Nutrition and Cancer

Volumn 38, Issue 1, 2000, Pages 123-130

  Lu, S ^a   Epner, D E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; DNA; HOMOCYSTEINE; METHIONINE; PROTEIN P21; PROTEIN P27;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL STRAIN; DRUG INHIBITION; ENZYME INHIBITION; FLOW CYTOMETRY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; PROSTATE CANCER; WESTERN BLOTTING;

EID: 0034447538     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC381_17     Document Type: Article

References (56)

1. Cancer statistics, 1999
2. Glutathione: An overview of biosynthesis and modulation
3. Alterations in DNA methylation: A fundamental aspect of neoplasia
4. Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect
5. The effect of choline on the ability of homocysteine to replace methionine in the diet
6. Decreased rat rhabdomyosarcoma pulmonary metastases in response to a low methionine diet
7. The effect of replacement of methionine by homocysteine on survival of malignant and normal adult mammalian cells in culture
8. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines
9. Methionine requirement of normal and leukaemic haemopoietic cells in short-term cultures
10. Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture
11. Elevated overall rates of transmethylation in cell lines from diverse human tumors
12. Effect of methionine deprivation on methylation and synthesis of macromolecules
13. Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells
14. Growth of methionine-dependent human prostate cancer (PC-3) is inhibited by ethionine combined with methionine starvation
15. Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo
16. Methionine dependency of malignant tumors: A possible approach for therapy
17. Anticancer efficacy of methioninase in vivo
18. Biological effects of enzymatic deprivation of L-methionine in cell culture and an experimental tumor
19. Differential sensitivity of normal and leukaemic haemopoietic cells to methionine deprivation by L-methioninase
20. Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase
21. Effect of long-term depletion of plasma methionine on the growth and survival of human brain tumor xenografts in athymic mice
22. Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: A randomized, prospective clinical trial
23. Reversible growth arrest in simian virus 40-transformed human fibroblasts
24. Unchecked DNA synthesis and blocked cell division induced by methionine deprivation in a human prostate cancer cell line
25. Regulation of androgen-dependent prostatic cancer cell growth: Androgen regulation of CDK2, CDK4, and CKI p16 genes
26. Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines
27. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles
28. p53 oncogene mutations in three human prostate cancer cell lines
29. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene
30. WAF1, a potential mediator of p53 tumor suppression
31. Cell cycle checkpoints: Preventing an identity crisis
32. Cancer cell cycles
33. 2 arrest after DNA damage
34. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age
35. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage
36. Cyclins and cell cycle checkpoints
37. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen
38. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor
39. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation, and carcinogenesis
40. S-adenosylmethionine and methylation
41. Function and synthesis of small nucleolar RNAs
42. Utilization of preformed and endogenously synthesized methionine by cells in tissue culture
43. Potential for selective modulation of glutathione in cancer chemotherapy
44. Clinical studies of reversal of drug resistance based on glutathione
45. Expression of Bcl-2 increases intracellular glutathione by inhibiting methionine-dependent GSH efflux
46. ASTRO research fellowship: The role of BCL-2 and glutathione in an antioxidant pathway to prevent radiation-induced apoptosis
47. Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols
48. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system
49. Glutathione-related mechanisms in cellular resistance to anticancer drugs
50. Methionine starvation modulates the efficacy of cisplatin on human breast cancer in nude mice
51. 3] methionine kinetics in humans: Methionine conservation and cystine sparing
52. Plasma and urinary amino acids and selected sulfur metabolites in young men fed a diet devoid of methionine and cystine
53. Treatment of homocystinuria with a low-methionine diet, supplemental cystine, and a methyl donor
54. Protocol 8 - Homocystinuria
55. Low methionine diet treatment of homocystinuria